Laboratory models examine how GLP-1 receptor activation in the brain by two formulations with distinct kinetics modulates food reward circuits, hunger signals, feeding behaviors, and central energy balance regulation mechanisms in a potentially differential and complementary manner
Theyre not only good for weight loss and managing diabetes, but evidence is accumulating that they protect from cardiovascular disease and early data shows that maybe they could help with addiction, Alzheimers disease, and a slew of other health issuesconfirmation in better studies is sorely needed
Similarly, the SCALE (Satiety and Clinical AdiposityLiraglutide Evidence) trials published in The Lancet (2015) demonstrated that liraglutide 3.0 mg daily resulted in approximately 8% weight loss over 56 weeks
Montazeri A, Sadighi J, Farzadi F, Maftoon F, Vahdaninia M, Ansari M, Sajadian A, Ebrahimi M, Haghighat S, Harirchi I (2008) Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study
